guest ::
| Home > Publications database > Authentically radiolabelled Mn(II) complexes as bimodal PET/MR tracers > print |
| Home > Publications database > Authentically radiolabelled Mn(II) complexes as bimodal PET/MR tracers > print |
| 001 | 825273 | ||
| 005 | 20210129225251.0 | ||
| 037 | _ | _ | |a FZJ-2016-07744 |
| 041 | _ | _ | |a English |
| 100 | 1 | _ | |a Vanasschen, Christian |0 P:(DE-Juel1)157902 |b 0 |e Corresponding author |u fzj |
| 111 | 2 | _ | |a 21st International Symposium on Radiopharmaceutical Sciences |g ISRS 2015 |c Columbia |d 2015-05-26 - 2015-05-31 |w USA |
| 245 | _ | _ | |a Authentically radiolabelled Mn(II) complexes as bimodal PET/MR tracers |
| 260 | _ | _ | |c 2015 |
| 336 | 7 | _ | |a Conference Paper |0 33 |2 EndNote |
| 336 | 7 | _ | |a INPROCEEDINGS |2 BibTeX |
| 336 | 7 | _ | |a conferenceObject |2 DRIVER |
| 336 | 7 | _ | |a CONFERENCE_POSTER |2 ORCID |
| 336 | 7 | _ | |a Output Types/Conference Poster |2 DataCite |
| 336 | 7 | _ | |a Poster |b poster |m poster |0 PUB:(DE-HGF)24 |s 1482503773_29337 |2 PUB:(DE-HGF) |x Plenary/Keynote |
| 520 | _ | _ | |a Objectives: Hybrid PET/MR imaging will pave the way for a better understanding of physiological and disease mechanisms in preclinical and clinical settings. Authentic radiolabeling of MR contrast agents ensures a fast and simple access to such bimodal tracers. In this case, a ligand chelating a paramagnetic metal ion (e.g. Mn) spiked with the authentic PET isotope (such as 52gMn) leads to a labelled molecule which can be detected with both imaging modalities. Paramagnetic [55Mn(CDTA)]2- shows an excellent compromise between thermodynamic stability, kinetic inertness and MR contrast enhancement [1]. The aim of this work was a proof of principle study of cyclohexanediaminetetraacetic acid (CDTA) ligands as prosthetic groups for Mn-labelled PET/MR tracers.Methods: N.c.a. 52gMn [t1/2: 5.6 d; Eβ+: 575.8 keV (29.6%)] was produced by proton irradiation of a natCr target and purified by cation-exchange chromatography [2]. CDTA radiolabeling with n.c.a. 52gMn2+ was performed in NaOAc buffer (1M, pH 6) at RT and monitored by radio-TLC as well as IC. Purification of the complex was performed by RP-HPLC and a test on stability in NaOAc buffer. A hydroxyalkyl functionalized CDTA ligand was synthesized starting from 3-cyclohexene-1-methanol in 5 steps.Results: The quantitative formation of [52gMn(CDTA)]2- was observed already within 30 min at RT. The complex was stable for at least 48 h at 50 °C. If an isotopic 52g/55Mn2+ mixture was applied the first prototypical manganese based bimodal PET/MR tracer was obtained. Furthermore, the hydroxyalkyl functionalized CDTA ligand was synthesized with an overall yield of 18-25%. Conclusions: Due to the hydrolytic stability and simple preparation of [52g/55Mn(CDTA)]2-, the CDTA ligand should be highly suitable for the preparation of manganese based PET/MR bimodal tracers. Acknowledgements: The authors thank M. Buchholz for production of 52gMnCl2.References: [1] Kalman, F. et al. (2012), Inorg. Chem., 51, 10065.[2] Buchholz, M. et al. (2013), Radiochim. Acta, 101, 491. |
| 536 | _ | _ | |a 573 - Neuroimaging (POF3-573) |0 G:(DE-HGF)POF3-573 |c POF3-573 |f POF III |x 0 |
| 700 | 1 | _ | |a Brandt, Marie |0 P:(DE-Juel1)162273 |b 1 |u fzj |
| 700 | 1 | _ | |a Ermert, Johannes |0 P:(DE-Juel1)131818 |b 2 |u fzj |
| 700 | 1 | _ | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 3 |u fzj |
| 700 | 1 | _ | |a Coenen, Heinrich Hubert |0 P:(DE-Juel1)131816 |b 4 |u fzj |
| 909 | C | O | |o oai:juser.fz-juelich.de:825273 |p VDB |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)157902 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)162273 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)131818 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)166419 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)131816 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |2 G:(DE-HGF)POF3-500 |v Neuroimaging |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2016 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-5-20090406 |k INM-5 |l Nuklearchemie |x 0 |
| 980 | _ | _ | |a poster |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|